MAU2 and hyperlipidemia: The minor allele carriers had higher serum levels of TC (NCAN rs2238675, NCAN rs2228603, TM6SF2 rs58542926, TM6SF2 rs735273, CILP2 rs16996148, and MAU2 rs968525), TG (TM6SF2 rs58542926, TM6SF2 rs735273, CILP2 rs16996148, CILP2 rs17216525, PBX4 rs12610185, SUGP1 rs10401969, and MAU2 rs8102280), and LDL-C (CILP2 rs16996148, MAU2 rs73001065, and MAU2 rs150268548) than the minor allele noncarriers in both hyperlipidemia and normal groups (P < 0.004 for all).